Literature DB >> 22940854

In silico structural and functional analysis of the human TOPK protein by structure modeling and molecular dynamics studies.

Palani Kirubakaran1, Muthusamy Karthikeyan, Kh Dhanachandra Singh, Selvaraman Nagamani, Kumpati Premkumar.   

Abstract

Over expression of T-lymphokine-activated killer cell-originated protein kinase (TOPK) has been associated with leukemia, myeloma tumors and various other cancers. The function and regulatory mechanism of TOPK in tumor cells remains unclear. Structural studies that could reveal the regulatory mechanism have been a challenge because of the unavailabity of TOPK's crystal structure. Hence, in this study, the 3D structure of TOPK protein has been constructed by using multiple templates. The quality and reliability of the generated model was checked and the molecular dynamics method was utilized to refine the model. APBS method was employed to know the electrostatic potential surface of the modeled protein and it was found that the optimum pH for protein stability is 3.4 which will further help in mechanistic hypothesis of TOPK protein. Active site of TOPK was identified from available literature and HTVS was employed to identify the lead molecules. The expected binding modes of protein-ligand complexes were reproduced in the MD simulation which indicates that the complex is relatively stable. The pharmacokinetic properties of the lead molecules are also under acceptable range. TOPK act as a substrate for CDK1 and the protein-protein docking and dynamics studies were carried out to analyze the effect of Thr9Ala mutation of TOPK in the two protein complex formation. It shows that the wild type complex is more stable when compared with the mutant type. Such structural information at atomic level not only exhibits the action modes of TOPK inhibitors but also furnishes a novel starting point for structure based drug design of TOPK inhibitors.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22940854     DOI: 10.1007/s00894-012-1566-1

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  35 in total

1.  Electrostatics of nanosystems: application to microtubules and the ribosome.

Authors:  N A Baker; D Sept; S Joseph; M J Holst; J A McCammon
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-21       Impact factor: 11.205

2.  Genome-scale approaches to resolving incongruence in molecular phylogenies.

Authors:  Antonis Rokas; Barry L Williams; Nicole King; Sean B Carroll
Journal:  Nature       Date:  2003-10-23       Impact factor: 49.962

3.  PDB2PQR: an automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations.

Authors:  Todd J Dolinsky; Jens E Nielsen; J Andrew McCammon; Nathan A Baker
Journal:  Nucleic Acids Res       Date:  2004-07-01       Impact factor: 16.971

4.  Characterization of a MAPKK-like protein kinase TOPK.

Authors:  Suguru Matsumoto; Yasuhito Abe; Taketsugu Fujibuchi; Takashi Takeuchi; Katsumi Kito; Norifumi Ueda; Kazuhiro Shigemoto; Kiyofumi Gyo
Journal:  Biochem Biophys Res Commun       Date:  2004-12-17       Impact factor: 3.575

5.  Structural and thermodynamic characterization of the TYK2 and JAK3 kinase domains in complex with CP-690550 and CMP-6.

Authors:  Jill E Chrencik; Akshay Patny; Iris K Leung; Brian Korniski; Thomas L Emmons; Troii Hall; Robin A Weinberg; Jennifer A Gormley; Jennifer M Williams; Jacqueline E Day; Jeffrey L Hirsch; James R Kiefer; Joseph W Leone; H David Fischer; Cynthia D Sommers; Horng-Chih Huang; E J Jacobsen; Ruth E Tenbrink; Alfredo G Tomasselli; Timothy E Benson
Journal:  J Mol Biol       Date:  2010-05-15       Impact factor: 5.469

6.  Crystal structures of IRAK-4 kinase in complex with inhibitors: a serine/threonine kinase with tyrosine as a gatekeeper.

Authors:  Zhulun Wang; Jinsong Liu; Athena Sudom; Merrill Ayres; Shyun Li; Holger Wesche; Jay P Powers; Nigel P C Walker
Journal:  Structure       Date:  2006-12       Impact factor: 5.006

7.  Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes.

Authors:  Richard A Friesner; Robert B Murphy; Matthew P Repasky; Leah L Frye; Jeremy R Greenwood; Thomas A Halgren; Paul C Sanschagrin; Daniel T Mainz
Journal:  J Med Chem       Date:  2006-10-19       Impact factor: 7.446

8.  Evaluation of comparative protein modeling by MODELLER.

Authors:  A Sali; L Potterton; F Yuan; H van Vlijmen; M Karplus
Journal:  Proteins       Date:  1995-11

9.  Expression of PDZ-binding kinase (PBK) is regulated by cell cycle-specific transcription factors E2F and CREB/ATF.

Authors:  Asit K Nandi; Aaron P Rapoport
Journal:  Leuk Res       Date:  2005-09-19       Impact factor: 3.156

10.  Modern homology modeling of G-protein coupled receptors: which structural template to use?

Authors:  Juan Carlos Mobarec; Roberto Sanchez; Marta Filizola
Journal:  J Med Chem       Date:  2009-08-27       Impact factor: 7.446

View more
  5 in total

1.  Enhanced hybrid search algorithm for protein structure prediction using the 3D-HP lattice model.

Authors:  Changjun Zhou; Caixia Hou; Qiang Zhang; Xiaopeng Wei
Journal:  J Mol Model       Date:  2013-07-04       Impact factor: 1.810

2.  Amyotrophic Lateral Sclerosis Type 20 - In Silico Analysis and Molecular Dynamics Simulation of hnRNPA1.

Authors:  Bruna Baumgarten Krebs; Joelma Freire De Mesquita
Journal:  PLoS One       Date:  2016-07-14       Impact factor: 3.240

3.  Pantoprazole, an FDA-approved proton-pump inhibitor, suppresses colorectal cancer growth by targeting T-cell-originated protein kinase.

Authors:  Xiaoyu Zeng; Lin Liu; Mengzhu Zheng; Huimin Sun; Juanjuan Xiao; Tao Lu; Guangqian Huang; Pianpian Chen; Jianmin Zhang; Feng Zhu; Hua Li; Qiuhong Duan
Journal:  Oncotarget       Date:  2016-04-19

4.  Proton pump inhibitor ilaprazole suppresses cancer growth by targeting T-cell-originated protein kinase.

Authors:  Mengzhu Zheng; Shanshan Luan; Suyu Gao; Li Cheng; Bin Hao; Jiacheng Li; Yao Chen; Xuemei Hou; Lixia Chen; Hua Li
Journal:  Oncotarget       Date:  2017-06-13

5.  TOPK promotes lung cancer resistance to EGFR tyrosine kinase inhibitors by phosphorylating and activating c-Jun.

Authors:  Ying Li; Zhiwei Yang; Weijie Li; Shudi Xu; Tao Wang; Ting Wang; Mengjie Niu; Shengli Zhang; Lintao Jia; Shengqing Li
Journal:  Oncotarget       Date:  2016-02-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.